• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Actinium Pharmaceuticals Inc (NY: ATNM )

    1.715 +0.005 (+0.29%)
    Streaming Delayed Price Updated: 11:06 AM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 40,262
    Open 1.710
    Bid (Size) 1.710 (101)
    Ask (Size) 1.720 (2)
    Prev. Close 1.710
    Today's Range 1.710 - 1.760
    52wk Range 1.330 - 10.24
    Shares Outstanding 21,331,314
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire

    Performance

    YTD
    -67.76%
    -67.76%
    1 Month
    -4.19%
    -4.19%
    3 Month
    -30.85%
    -30.85%
    6 Month
    -80.60%
    -80.60%
    1 Year
    -62.31%
    -62.31%

    More News

    Read More
    Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    ATNM Investors Have Opportunity to Join Actinium Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    ATNM Stock Earnings: Actinium Pharmaceuticals Beats EPS for Q2 2024
    Via InvestorPlace
    Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Dow Tumbles 950 Points; ISM Services PMI Surges In July
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia Treatment
    Via Benzinga
    Exposures Product Safety
    Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views
    Via Benzinga
    3 Under-$10 Biotech Stocks That Could Make You Rich
    Via InvestorPlace
    3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns
    Via InvestorPlace
    Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions
    Via Newsfile
    Actinium Presents Exciting Data On Leukemic Cell Killing in Preclinical Acute Myeloid Leukemia Models at the 2024 EHA Congress
    Via AB Newswire
    Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase
    Via FinancialNewsMedia
    Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase
    From FN Media Group LLC
    Via GlobeNewswire
    Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
    Via FinancialNewsMedia
    Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML)
    Via Newsfile
    Actinium Presents First Ever Data Demonstrating Statistically Significant Anti-Tumor Control and Potent Leukemic Cell Killing with Actimab-A in Combination with Leading Menin Inhibitors in Preclinical Acute Myeloid Leukemia Models at the 2024 EHA Congress
    Via FinancialNewsMedia
    Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at EHA Congress
    Via AB Newswire
    Topics Intellectual Property
    Exposures Intellectual Property
    Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024
    Via InvestorPlace
    Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
    Via InvestorPlace
    3 Cheap Biotech Stocks to Buy Now: May 2024
    Via InvestorPlace
    Exposures Product Safety
    Actinium Pharmaceuticals (ATNM) Poised for Breakout as Analysts Project Significant Upside
    Via AB Newswire
    Actinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions
    Via AB Newswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.